EWTX
Companies
NASDAQ
Edgewise Therapeutics Inc.
Health Care
$14.46
-$12.24 (-45.84%)
Price Chart
Overview
About EWTX
edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from orbimed.
Market Cap
$1.6B
Volume
15.3M
Avg. Volume
20.3M
P/E Ratio
-7.891892
Dividend Yield
0.00%
Employees
85.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.92
Moderate Correlation
Volatility
High (0.82)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, EWTX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$1.6B
Volume15.3M
P/E Ratio-7.89
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 8, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025